Related Experiment Video
Updated: Jun 20, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Screening tests for inflammatory activity: applications in rheumatology.
Nilton Salles Rosa Neto1, Jozélio Freire de Carvalho, Yehuda Shoenfeld
1Department of Rheumatology, University of São Paulo School of Medicine Hospital das Clínicas, São Paulo, Brazil.
Inflammation is key in rheumatic diseases. Analyzing inflammatory biomarkers, like C-reactive protein and erythrocyte sedimentation rate, helps assess disease activity and treatment effectiveness.
Area of Science:
- Rheumatology
- Immunology
- Biochemistry
Background:
- Inflammation is a critical component of rheumatic diseases, involving complex biological responses to tissue injury.
- Serum concentrations of specific proteins, known as inflammatory biomarkers, change during these responses.
- These biomarkers are crucial for understanding disease processes and patient outcomes.
Purpose of the Study:
- To review the characteristics of various inflammatory biomarkers.
- To discuss the application of these biomarkers in assessing inflammatory activity in rheumatic diseases.
- To highlight their role in monitoring disease progression and treatment efficacy.
Main Methods:
- Review of existing literature on inflammatory biomarkers in rheumatic diseases.
- Analysis of the role of C-reactive protein, erythrocyte sedimentation rate, and protein electrophoresis.
- Correlation of biomarker levels with clinical data and other diagnostic tests.
Main Results:
- Inflammatory biomarkers provide objective measures of disease activity in rheumatic conditions.
- Changes in biomarker levels correlate with treatment response and disease flares.
- Screening tests like C-reactive protein and erythrocyte sedimentation rate are valuable diagnostic tools.
Conclusions:
- Inflammatory biomarkers are essential for diagnosing and managing rheumatic diseases.
- Laboratory analysis of these markers aids in assessing disease severity and guiding therapeutic decisions.
- Integrating biomarker data with clinical findings offers a comprehensive approach to patient care.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
